The utility of growth differentiation factor-15, galectin-3, and sST2 as biomarkers for the diagnosis of heart failure with preserved ejection fraction and compared to heart failure with reduced ejection fraction: a systematic review-Reference-Cited by-同舟云学术

The utility of growth differentiation factor-15, galectin-3, and sST2 as biomarkers for the diagnosis of heart failure with preserved ejection fraction and compared to heart failure with reduced ejection fraction: a systematic review

Published:2020-05-29 Issue:4 Volume:26 Page:799-812
ISSN:1382-4147
Container-title:Heart Failure Reviews
language:en
Short-container-title:Heart Fail Rev

Author:

Rabkin Simon W.^ORCID,Tang Jacky K. K.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10741-020-09913-3.pdf

Reference62 articles.

1. Borlaug BA, Paulus WJ (2011) Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J 32:670–679

2. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM (2006) Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355:251–259. https://doi.org/10.1056/NEJMoa052256

3. Chow B, Rabkin SW (2015) The relationship between arterial stiffness and heart failure with preserved ejection fraction: a systemic meta-analysis. Heart Fail Rev 20:291–303. https://doi.org/10.1007/s10741-015-9471-1

4. Warbrick I, Rabkin SW (2019) Effect of the peptides relaxin, neuregulin, ghrelin and glucagon-like prptide-1 on cardiomyocyte factors involved in the molecular mechanisms leading to diastolic dysfunction and/or heart failure with preserved ejection fraction. Peptides 111:33–41

5. Warbrick I, Rabkin SW (2019) Hypoxia-inducible factor 1-alpha (HIF-1α) as a factor mediating the relationship between obesity and heart failure with preserved ejection fraction. Obes Rev 20:291–303

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical determinants and biomarkers associated with cardiac fibrosis after heart transplantation as assessed by magnetic resonance: Size matters;IJC Heart & Vasculature;2024-10

2. Changes in the concentration of sST2, activity of myeloperoxidase, and inducible NO-synthase in serum and lymphocytes as an indicator of disease severity in patients with arterial hypertension and against the background of coronavirus disease;Experimental and Clinical Physiology and Biochemistry;2024-09-04

3. Biomarkers in Heart Failure with Preserved Ejection Fraction: A Perpetually Evolving Frontier;Journal of Clinical Medicine;2024-08-07

4. Effect of extended-release metformin on humoral cardiometabolic markers and lipid peroxidation parameters in patients with prediabetes, heart failure with preserved ejection fraction and abdominal obesity;Cardiovascular Therapy and Prevention;2024-07-24

5. PROGRESSO NO TRATAMENTO DA INSUFICIÊNCIA CARDÍACA CRÔNICA: ABORDAGENS INOVADORAS E PRÁTICAS CLÍNICAS ATUALIZADAS;International Journal of Health Management Review;2024-07-22